Designed Proteins Neutralize Snake Venom — and Hint at Antivenom Without the Horses
Lab-designed proteins neutralized lethal snake venom toxins in mice, pointing toward cheaper, heat-stable antivenom. Inside the Nature study and what it means.
A protein drawn on a computer protected mice from lethal cobra toxins. The century-old way of making antivenom may finally have a rival.
Most antivenom is still made the way it was made in the 1890s. Inject a horse with small doses of venom, wait for its immune system to respond, harvest the antibodies from its blood, purify, repeat. The serum saves lives, and it carries real costs: it is expensive, it spoils in the heat where snakebites happen most, and it can trigger dangerous allergic reactions because it is, after all, horse protein.
A January 2025 paper in Nature points somewhere else entirely. Researchers designed proteins to neutralize snake venom from scratch — no animal, no antibody — and showed the lab-built molecules protected mice from otherwise lethal doses. The work came from the Institute for Protein Design in Seattle, part of the same computational-design revolution that earned David Baker a share of the 2024 Nobel Prize in Chemistry.
Targeting the toxins that stop the nerves
The team aimed at three-finger toxins, the small, stable proteins that make cobra and krait venom so deadly. These toxins jam the signal between nerve and muscle; a bad bite ends in paralysis and suffocation. They are also notoriously hard for traditional antivenom to mop up.
Rather than search nature for a countermeasure, the researchers designed binders to grip these toxins precisely, expressed them in ordinary bacteria, and tested them against the real poison. The designed proteins latched on, neutralized the toxins, and kept the animals alive. The molecules were small, stable, and — crucially — manufacturable in a fermenter rather than a stable.
Why are heat-stable and cheap changes the map
Snakebite envenoming kills an estimated 100,000 people a year and maims many more, according to the World Health Organization, which classifies it as a neglected tropical disease. The victims are overwhelmingly rural, poor, and far from the cold chain that conventional antivenom demands.
A designed protein rewrites those constraints. Brew it cheaply in bacteria, and the price falls. Build it to survive warmth, and it reaches the clinics that need it. Target a specific toxin, and you avoid the scattershot immune mixtures that cause reactions. None of that is guaranteed yet — but each is a plausible property of a designed molecule in a way it never was for horse serum.
A proof of principle, not a product
The honest framing matters. This is early-stage science: a demonstration in mice against particular toxins, not a therapy sitting in a pharmacy. Snake venom is a cocktail, and different snakes carry different poisons; a real product would need to cover the toxins that matter in a given region, then clear safety and efficacy testing in people. That is years of work.
What the study proves is that the approach can work at all. A protein conceived on a screen can neutralize one of nature’s most refined weapons in a living animal. For a problem that has resisted better answers for generations, that is not a footnote.
The bigger pattern
The same design tools reshaping obesity and diabetes pipelines are being pointed at diseases the market has long ignored. Antivenom is not a blockbuster category; it is a humanitarian one, chronically underfunded because its patients cannot pay. Computational design lowers the cost of trying, which is exactly what neglected diseases have always lacked.
For readers tracking where peptide and protein engineering goes next, snakebite is a tell. When designing a countermeasure gets cheap enough, the molecules nobody could justify making suddenly get made.
Frequently asked questions
How is antivenom made today? Mostly the way it was in the 1890s: inject a horse with small doses of venom, let its immune system respond, then harvest and purify the antibodies from its blood. The serum works but is costly, needs refrigeration, and can trigger allergic reactions.
Could designed proteins replace antivenom? Possibly, in time. The 2025 Nature study showed lab-designed proteins neutralized lethal cobra toxins in mice. Because they can be brewed cheaply in bacteria and engineered to be heat-stable, they could sidestep the cost and cold-chain problems — but this is early-stage science, years from a product.
How many people die from snakebites? The World Health Organization estimates snakebite envenoming kills around 100,000 people a year, overwhelmingly in rural, low-income regions, and classifies it as a neglected tropical disease.
Sources
- Vázquez-Torres, S. et al. “De novo designed proteins neutralize lethal snake venom toxins.” Nature, January 2025. DOI: 10.1038/s41586-024-08393-x.
- Institute for Protein Design, University of Washington — research announcement on designed antivenom proteins.
- World Health Organization — Snakebite envenoming fact sheet and Neglected Tropical Diseases program.
- The Royal Swedish Academy of Sciences — Nobel Prize in Chemistry 2024 (David Baker), nobelprize.org.